In-Silico Drug Discovery Market
完整報告名稱與涵蓋範圍
In-Silico Drug Discovery Market Size, Share & Trends Analysis Report By Products (Software, Software-as-a-Service (SaaS), Consultancy-as-a-Service), By Workflow (Discovery, Pre-Clinical Tests, Clinical Trials), By Technology, By Software Type, By End User, By Region, And By Segment Forecasts, 2025-2034
報告摘要
The worldwide In-Silico Drug Discovery Market stood at USD 3.4 Billion in 2024, and is projected to reach USD 12.8 Billion by 2034, recording a CAGR of 14.5% from 2025 through 2034.
In-Silico Drug Discovery encompasses key industry insights & findings from the report:
The growing emphasis on minimizing prescription errors, technological developments in computational biology, and the expanding usage of cloud-based t. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is underpinned by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global In-Silico Drug Discovery Market Snapshot
Chapter 4. Global In-Silico Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Software Type Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Software
5.2.2. Software-as-a-Service (Cloud)
5.2.3. Consultancy-as-a-Service
Chapter 6. Market Segmentation 2: By Workflow Estimates & Trend Analysis
6.1. By Workflow & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow:
6.2.1. Discovery
6.2.1.1. Target Identification
6.2.1.1.1. Bioinformatics
6.2.1.1.2. Reverse Docking
6.2.1.1.3. Protein Structure Prediction
6.2.1.2. Target Validation
6.2.1.3. Lead Discovery
6.2.1.3.1. Library Design
6.2.1.3.2. Pharmacophore
6.2.2. Pre-Clinical Tests
6.2.3. Clinical Trials
Chapter 7. Market Segmentation 3: By Software Type Estimates & Trend Analysis
7.1. By Software Type & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Software Type:
7.2.1. Molecular Modeling and De Novo Drug Design Software
7.2.2. Pharmacophore Modeling Software
Chapter 8. Market Segmentation 4: By Technology Estimates & Trend Analysis
8.1. By Technology & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
8.2.1. Artificial Intelligence
8.2.1.1. Computational Methods Used by Advanced AI Companies
8.2.1.2. Use of Artificial Intelligence to Combat COVID-19 Pandemic
8.2.2. Graphics Processing Unit
8.2.3. Other Technologies
8.2.3.1. In-Silico Fishing
8.2.3.2. RNN for Drug Design
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By End User & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
9.2.1. Contract Research Organizations
9.2.2. Pharmaceutical and Biopharmaceutical Companies
9.2.3. Academic and Research Institutes
9.2.4. Other End Users (Hospitals and Other Care Facilities)
Chapter 10. In-Silico Drug Discovery Market Segmentation 7: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
10.1.2. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts By Workflow, 2021-2034
10.1.3. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts By Software Type, 2021-2034
10.1.4. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.1.5. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.1.6. North America In-Silico Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe In-Silico Drug Discovery Market revenue (US$ Million) By Product, 2021-2034
10.2.2. Europe In-Silico Drug Discovery Market revenue (US$ Million) By Workflow, 2021-2034
10.2.3. Europe In-Silico Drug Discovery Market revenue (US$ Million) By Software Type, 2021-2034
10.2.4. Europe In-Silico Drug Discovery Market revenue (US$ Million) By Technology, 2021-2034
10.2.5. Europe In-Silico Drug Discovery Market revenue (US$ Million) By End User, 2021-2034
10.2.6. Europe In-Silico Drug Discovery Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) By Product, 2021-2034
10.3.2. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) By Workflow, 2021-2034
10.3.3. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) By Software Type, 2021-2034
10.3.4. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) By Technology, 2021-2034
10.3.5. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) By End User, 2021-2034
10.3.6. Asia Pacific In-Silico Drug Discovery Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America In-Silico Drug Discovery Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
10.4.2. Latin America In-Silico Drug Discovery Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
10.4.3. Latin America In-Silico Drug Discovery Market revenue (US$ Million) By Software Type, (US$ Million) 2021-2034
10.4.4. Latin America In-Silico Drug Discovery Market revenue (US$ Million) By Technology, (US$ Million) 2021-2034
10.4.5. Latin America In-Silico Drug Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
10.4.6. Latin America In-Silico Drug Discovery Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
10.5.2. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) By Workflow, (US$ Million) 2021-2034
10.5.3. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) By Software Type, (US$ Million) 2021-2034
10.5.4. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) By Technology, (US$ Million) 2021-2034
10.5.5. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
10.5.6. Middle East & Africa In-Silico Drug Discovery Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Aragen Life Sciences Pvt. Ltd. (GVK Biosciences Pvt. Ltd.)
11.2.2. Curia Global, Inc. (Albany Molecular Research Inc.)
11.2.3. Certara, USA.
11.2.4. Charles River
11.2.5. Chemical Computing Group ULC. (CCG)
11.2.6. Collaborative Drug Discovery Inc. (CDD)
11.2.7. Dassault Systemes
11.2.8. e-therapeutics plc.
11.2.9. Evotec (Cyprotex)
11.2.10. Insilico Medicine
11.2.11. Ligand Pharmaceuticals Incorporated (Icagen, Inc.)
11.2.12. Numerate, Inc.
11.2.13. PerkinElmer Inc.
11.2.14. Schrödinger, Inc.
11.2.15. Selvita
11.2.16. Simulations Plus
11.2.17. Tracxn Technologies (Novo Informatics Pvt. Ltd.)
11.2.18. WuXi AppTec
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們